Switching From Oral Dopamine Agonists to Rotigotine

Summary

The primary objective is to demonstrate safety and tolerability of switching patients with Restless Legs Syndrome (RLS) from an oral dopamine agonist to rotigotine. As a secondary objective, the investigators will evaluate control of RLS symptoms on rotigotine compared to the prior oral regimen.

Timeline

Start

2014-08

Primary completion

2015-05

Completion

2015-12

Drugs

Indications